Laboratory tests prescription Not Applicable
Conditions
Interventions
The control group continued to use the usual version of the EHR software (SAM). The intervention group used a modified version of the software (SAM modified) installed in each server. The modification
Sponsors
AstraZeneca HealthCare Foundation (Portugal)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All family physicians working and prescribing diagnostic and laboratory tests in the Western Oporto group of health centers (except those where the authors worked)
Exclusion criteria
Exclusion criteria: Family physicians working in the same health center as the researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes were chosen to assess the impact of our intervention in the number of diagnostic and laboratory tests prescribed by physicians including four different perspectives: 1. Impact on the number of the prescriptions of diagnostic and laboratory tests that were withdrawn from the basic menu 2. Impact on the number of the prescriptions of diagnostic and laboratory tests that were added to the basic menu 3. Impact on the number of the prescriptions of diagnostic and laboratory tests that were marked with green dots (USPSTF recommendations grade A and B) 4. Impact on the number of prescriptions of diagnostic and laboratory tests that were marked with red dots (USPSTF recommendations grade D) Prospective monthly monitoring and data collection occurred until 31/01/2013. To allow a pre-post analysis in both groups, a retrospective monthly data collection of both control and intervention groups was also performed between 01/12/2011 and 31/05/2012. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Monthly number of family physicians prescribing 2. Monthly number of face-to-face consultations made 3. Monthly number of each diagnostic 4. Laboratory test prescribed Prospective monthly monitoring and data collection occurred until 31/01/2013. To allow a pre-post analysis in both groups, a retrospective monthly data collection of both control and intervention groups was also performed between 01/12/2011 and 31/05/2012. | — |
Countries
Portugal
Outcome results
None listed